Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

BiSCUIT · Biomimetic Sensorized Barriers-on-a-Chip: Unveiling a new Generation of Market-Ready Investigation Tools

HORIZONStatus: SIGNED1 July 202431 December 2025EU funding €150,000Call ERC-2023-POC

The lack of reliable in vitro pre-clinical models represents a critical aspect unanimously recognized by the scientific community as detrimental in the pathway of bringing new medications from the laboratory to the bedside: addressing this issue would provide immense benefits to drug discovery and development processes, by ethically limiting animal testing and drastically reducing costly failures in clinical trials. To date, most in vitro models fail at recapitulating the physiological microenvironment, and this often results in misleading data withdrawal. Starting from my prototype of real scale, dynamic and biomimetic blood-brain barrier model, in this project I aim at the validation of my system, after an upgrade step consisting in embedding sensing features in the platform, thus allowing a real-time evaluation of barrier formation and integrity maintenance. Characterized by microcapillary size/fenestrations and fluid flows similar to the in vivo physiological barrier, my tool will represent a drastic innovation over other well-established models in the literature and available on the market, allowing a reliable reproduction of the physiological environment and an accurate estimation of the amount of drug and/or nanomaterial concentration delivered through the barrier. Validation will be performed in relevant conditions, by implementing stroke and brain cancer models. All artificial components will be fabricated through two-photon polymerization (2pp), a disruptive mesoscale lithography technique that allows the fast fabrication of low-cost structures with resolution up to the nanometer scale, as well as great levels of scaffold reproducibility/accuracy. The proposed platform can be easily adopted in research laboratories and pharmaceutical industries as an advanced pre-clinical model, the primary biomedical applications of which consist in reliable screenings of drugs against pathologies of the central nervous system.

Consortium · 1 organisation

coordinator

FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA

IT · €150,000

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.